Improving Outcomes in Resectable Gastric Cancer: A Review of Current and Future Strategies
about
Weekday of Surgery Affects Postoperative Complications and Long-Term Survival of Chinese Gastric Cancer Patients after Curative Gastrectomy.Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy.Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway.Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis.The role of adrenomedullin in the pathogenesis of gastric cancer.Medical management of gastric cancer: a 2017 update.Expression of gremlin1 in gastric cancer and its clinical significance.A gene expression-based risk model reveals prognosis of gastric cancer.MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.Outlooks on Epstein-Barr virus associated gastric cancer.Osteoporosis and fracture after gastrectomy for stomach cancer: A nationwide claims study.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification.Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
P2860
Q33623988-2E9288A5-F956-463E-9983-398E0B60F8B0Q37412002-BBD7125B-0C25-409F-9105-C00E9FAFCF49Q40101289-EA40A0CD-526D-41A5-95AC-716D37E719B2Q41345691-CDF20653-4704-4918-97A8-B409808F0892Q46148814-1CF51FCC-E24F-4CB2-A6A4-17E77BDB8DA7Q47312688-84B83B2A-4630-4D04-B24E-C89029FBED4EQ48111976-BBDC1F22-2BDE-443F-B44B-F1BBAB6901D3Q49202365-D758E5E5-BE21-4FA6-BCCB-3D618254994AQ52670954-6C849B41-755A-4E51-B0B8-6A7196EE0479Q52720624-197B1602-A179-496B-A171-0B28B9D14DA9Q55324530-60E10331-5383-4739-9CAC-BE93032ED73BQ55403266-65DA984E-8A64-4BE4-BA29-A2C0BF13EEDCQ55690221-429EF489-414C-4A93-BB80-F607CB561068Q58694894-5109D888-CC24-4695-98C5-4CB2A24BA74A
P2860
Improving Outcomes in Resectable Gastric Cancer: A Review of Current and Future Strategies
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Improving Outcomes in Resectab ...... Current and Future Strategies
@ast
Improving Outcomes in Resectab ...... Current and Future Strategies
@en
Improving Outcomes in Resectab ...... Current and Future Strategies
@nl
type
label
Improving Outcomes in Resectab ...... Current and Future Strategies
@ast
Improving Outcomes in Resectab ...... Current and Future Strategies
@en
Improving Outcomes in Resectab ...... Current and Future Strategies
@nl
prefLabel
Improving Outcomes in Resectab ...... Current and Future Strategies
@ast
Improving Outcomes in Resectab ...... Current and Future Strategies
@en
Improving Outcomes in Resectab ...... Current and Future Strategies
@nl
P2093
P1433
P1476
Improving Outcomes in Resectab ...... Current and Future Strategies
@en
P2093
Bryan A Chan
Carol J Swallow
Elena Elimova
Gail E Darling
Raymond W Jang
Rebecca K S Wong
P304
P407
P577
2016-07-01T00:00:00Z